Association between sociodemographic and clinical features, health behaviors, and health literacy of patients with prostate cancer and prostate cancer prognostic stage
Autores da FMUP
Participantes de fora da FMUP
- Braga, R
- Ara?jo, N.
- Silva, I
- Braga, I
- Pacheco Figueiredo, L
- Oliveira, J
- Morais, S
- Tedim Cruz, V
- Ferreira, S.
Unidades de investigação
Abstract
<jats:p>Patient characteristics may influence access and acceptance of Prostate Specific Antigen test, and therefore, the timing of prostate cancer (PCa) diagnosis. A group of 361 patients from a cohort (n?=?451) diagnosed with PCa in 2018?2020 at the Portuguese Institute of Oncology of Porto was evaluated before treatment, using a structured interview, the Medical Term Recognition Test, and the EORTC Quality of Life Questionnaire QLQ-PR25. PCa prognostic stages (I, II, III, IV) were attributed according to the American Joint Committee on Cancer eighth edition. Multinomial logistic regression was used to compute the odds ratio and 95% confidence interval (OR [95% CI]), considering PCa stage II, the most frequent, as reference. Older age (OR?=?4.21 [2.24?7.93]), living outside the Porto Metropolitan Area while having low income (OR?=?6.25 [1.53?25.62]), and erectile dysfunction (OR?=?2.22 [0.99?4.99]) were associated with stage III, while urination during the night (OR?=?3.02 [1.42?6.41]) was associated with stage IV. Urine leakage was less frequent in stage III (OR?=?0.23 [0.08?0.68]), and living with a partner (OR?=?0.41 [0.19?0.88]) and family history of cancer (OR?=?0.25 [0.07?0.86]) in stage IV. Health literacy was not associated with PCa stage but lower education was less frequent in stage I (OR?=?0.27 [0.11?0.69]). Patient sociodemographic and clinical characteristics should be considered as targets to improve PCa early detection and prognosis.</jats:p>
Dados da publicação
- ISSN/ISSNe:
- 1473-5709, 0959-8278
- Tipo:
- Article
- Páginas:
- 243-251
- Link para outro recurso:
- www.scopus.com
EUROPEAN JOURNAL OF CANCER PREVENTION Lippincott Williams and Wilkins Ltd.
Documentos
- Não há documentos
Filiações
Filiações não disponíveis
Keywords
- early diagnosis; health literacy; prostate cancer; sociodemographic factors
Proyectos asociados
Impacto da COVID-19 nas taxas de cesarianas por classificação de Robson nos hospitais portugueses.
Investigador Principal: Ricardo João Cruz Correia
Estudo Observacional Académico (Cesarianas) . 2020
Predição do resultado neonatal baseado na idade gestacional e peso ao nascimento: uma graduação de risco para cenários de nascimento com poucos recursos.
Investigador Principal: Ricardo João Cruz Correia
Estudo Observacional Académico (NEONATAL) . 2019
Desenvolvimento de uma escala de risco COVID-19 através de uma análise I&D probabilística de Monte Carlo de forma a dotar o Hospital de Ovar de planos de contingência adaptados para gestão de casos de Pandemia. (COVID-19)
Investigador Principal: Ricardo João Cruz Correia
Estudo Clínico Académico (COVID-19) . FCT . 2020
Excess mortality during COVID-19 in 5 european countries and a critique of mortality data analysis
Investigador Principal: Ricardo João Cruz Correia
Estudo Clínico Académico (Mortality) . 2020
Quality of Life after Transient Ischemic Attack
Investigador Principal: Andreia Filipa Gomes da Costa
Estudo Clínico Académico (Transient) . 2021
The role of hepatocyte apoptosis markers in predicting the histological and serological activity in steatohepatitis
Investigador Principal: Maria de Fátima Machado Henriques Carneiro
Estudo Clínico Académico . 2021
Treatment of acute exacerbations of trigeminal neuralgia in the emergency department – a retrospective study
Investigador Principal: Andreia Filipa Gomes da Costa
Estudo Clínico Académico (Neuralgia) . 2022
Diagnosis and management of acute primary headaches in adults in the emergency department
Investigador Principal: Andreia Filipa Gomes da Costa
Estudo Clínico Académico . 2022
Persistent headache attributed to past cervicocephalic artery dissection: clinical characterization and predictors of headache persistence
Investigador Principal: Andreia Filipa Gomes da Costa
Estudo Clínico Académico . 2022
Physical Activity in Young Relapsing Remitting Multiple Sclerosis Patients – A case-control study
Investigador Principal: Andreia Filipa Gomes da Costa
Estudo Clínico Académico . 2022
Breast cancer heterogeneity - etiology, clinical management, use of health resources and survival
Investigador Principal: Nuno Miguel de Sousa Lunet
Estudo Clínico Académico . 2022
Longitudinal Assessment of Cognitive Decline in Breast and Prostate Cancer Survivors
Investigador Principal: Nuno Miguel de Sousa Lunet
Estudo Clínico Académico (Cognitive Decline) . 2022
Healthcare use among cancer patients and their partners in different phases of the cancer pathway
Investigador Principal: Nuno Miguel de Sousa Lunet
Estudo Clínico Académico . 2021
Reshaping organized cervical cancer screening: strategies to increase the adherence and reduce invitation costs
Investigador Principal: Nuno Miguel de Sousa Lunet
Estudo Clínico Académico . 2020
Using pooled analyses based on individual participant data for a finer assessment of gastric cancer etiology
Investigador Principal: Nuno Miguel de Sousa Lunet
Estudo Clínico Académico . 2020
Gastric Cancer Morphological, Immunophenotypic and molecular heterogeneity
Investigador Principal: Maria de Fátima Machado Henriques Carneiro
Estudo Clínico Académico . 2020
Tracking the acquisition of eating habits in children and its effects on behaviours related to appetite
Investigador Principal: Carla Maria de Moura Lopes
Estudo Clínico Académico . 2019
RISK AND SURVIVAL OF GASTRIC CANCER RELATES SECOND PRIMARY TUMOURS: A COMPETING RISKS FRAMEWORK
Investigador Principal: Nuno Miguel de Sousa Lunet
Estudo Clínico Académico . 2019
Citar a publicação
Braga R,Ara?jo N,Costa A,Lopes C,Silva I,Correia R,Carneiro F,Braga I,Pacheco L,Oliveira J,Morais S,Tedim V,Ferreira S,Lunet N. Association between sociodemographic and clinical features, health behaviors, and health literacy of patients with prostate cancer and prostate cancer prognostic stage. Eur. J. Cancer Prev. 2023. 33. (3):p. 243-251. IF:2,400. (4).